Immunometabolic Markers in a Small Patient Cohort Undergoing Immunotherapy

Although the discovery of immune checkpoints was hailed as a major breakthrough in cancer therapy, generating a sufficient response to immunotherapy is still limited. Thus, the objective of this exploratory, hypothesis-generating study was to identify potentially novel peripheral biomarkers and disc...

Descripción completa

Detalles Bibliográficos
Autores principales: Hofbauer, Joshua, Hauck, Andreas, Matos, Carina, Babl, Nathalie, Decking, Sonja-Maria, Rechenmacher, Michael, Schulz, Christian, Regotta, Sabine, Mickler, Marion, Haferkamp, Sebastian, Siska, Peter J., Herr, Wolfgang, Renner, Kathrin, Kreutz, Marina, Schnell, Annette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139165/
https://www.ncbi.nlm.nih.gov/pubmed/35625643
http://dx.doi.org/10.3390/biom12050716

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139165/
https://www.ncbi.nlm.nih.gov/pubmed/35625643
http://dx.doi.org/10.3390/biom12050716

Ejemplares similares